Medable Acquires Mobile Applications from LEO Pharma

Medable Inc. (Palo Alto, CA), a software provider for patient-centered clinical trials, has announced that it has acquired LEO Innovation Lab’s Omhu A/S, a Denmark-based digital health tech company.

Omhu was launched in 2020 to develop new ways of supporting patients and doctors when diagnosing, managing, and treating skin conditions. As part of the agreement with LEO Pharma (owner of LEO Innovation Lab), Medable will take over the Omhu mobile applications and a team of 38 people with significant experience in digital health and artificial intelligence.

The acquisition expands Medable’s global engineering talent and gives Medable a third location in Europe, building on its European headquarters in Dublin, Ireland, launched last July, along with a Switzerland office outside the Greater Zurich area established last fall.

Omhu’s software applications include Imagine, a skin-tracking mobile app; Omhu Care, a telemedicine app; and Hudsvar, a triage telemedicine solution.

“LEO Innovation Lab has a strong track record developing transformative patient-centered digital solutions, and the technology and team at Omhu exemplify that,” said Tim Smith, chief technology officer and co-founder of Medable. “We’re thrilled to add Omhu’s patient-centered solutions to our platform, and we welcome the innovative and talented Omhu team to Medable.”